The Chemours Company
CC
$14.12
$0.130.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.78B | 5.80B | 5.79B | 5.89B | 6.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.78B | 5.80B | 5.79B | 5.89B | 6.08B |
| Cost of Revenue | 4.63B | 4.67B | 4.67B | 4.67B | 4.77B |
| Gross Profit | 1.15B | 1.13B | 1.12B | 1.22B | 1.31B |
| SG&A Expenses | 603.00M | 537.00M | 563.00M | 598.00M | 579.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.34B | 5.31B | 5.34B | 5.38B | 5.46B |
| Operating Income | 439.00M | 487.00M | 449.00M | 516.00M | 619.00M |
| Income Before Tax | 128.00M | 50.00M | 93.00M | -422.00M | -316.00M |
| Income Tax Expenses | 41.00M | -29.00M | -25.00M | -94.00M | -81.00M |
| Earnings from Continuing Operations | 87.00 | 79.00 | 118.00 | -328.00 | -235.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -2.00M | -2.00M | -2.00M | -2.00M |
| Net Income | 87.00M | 77.00M | 116.00M | -330.00M | -237.00M |
| EBIT | 439.00M | 487.00M | 449.00M | 516.00M | 619.00M |
| EBITDA | 740.00M | 784.00M | 744.00M | 815.00M | 926.00M |
| EPS Basic | 0.58 | 0.52 | 0.78 | -2.21 | -1.59 |
| Normalized Basic EPS | 0.94 | 1.10 | 0.97 | 1.34 | 1.85 |
| EPS Diluted | 0.56 | 0.49 | 0.75 | -2.23 | -1.61 |
| Normalized Diluted EPS | 0.94 | 1.09 | 0.97 | 1.34 | 1.84 |
| Average Basic Shares Outstanding | 597.97M | 597.01M | 595.93M | 595.62M | 595.58M |
| Average Diluted Shares Outstanding | 599.70M | 598.73M | 599.22M | 598.19M | 599.32M |
| Dividend Per Share | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Payout Ratio | 170.11% | 193.51% | 127.59% | -45.15% | -62.87% |
